BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8313545)

  • 1. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.
    Marshall HW; Morrison LC; Wu LL; Anderson JL; Corneli PS; Stauffer DM; Allen A; Karagounis LA; Ward RH
    Circulation; 1994 Feb; 89(2):567-77. PubMed ID: 8313545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme and apolipoproteins genes polymorphism in coronary artery disease.
    Mansur AP; Annicchino-Bizzacchi J; Favarato D; Avakian SD; César LA; Ramires JA
    Clin Cardiol; 2000 May; 23(5):335-40. PubMed ID: 10803441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS
    Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MspI restriction fragment length polymorphism 3' to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Civeira F; Genest J; Pocovi M; Salem DN; Herbert PN; Wilson PW; Schaefer EJ; Ordovas JM
    Atherosclerosis; 1992 Feb; 92(2-3):165-76. PubMed ID: 1352975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
    Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
    Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The X-X-/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample.
    Scartezini M; Zago MA; Chautard-Freire-Maia EA; Pazin-Filho A; Marin-Neto JA; Hotta JK; Nascimento AJ; Dos-Santos JE
    Braz J Med Biol Res; 2003 Mar; 36(3):369-75. PubMed ID: 12640502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single effects of apolipoprotein B, (a), and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein(a) genotypes and the risk of coronary artery disease in Czech male caucasians.
    Benes P; Muzík J; Benedík J; Frélich M; Elbl L; Vasků A; Znojil V; Vácha J
    Mol Genet Metab; 2000 Feb; 69(2):137-43. PubMed ID: 10720441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
    Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
    Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals.
    Peacock R; Dunning A; Hamsten A; Tornvall P; Humphries S; Talmud P
    Atherosclerosis; 1992 Feb; 92(2-3):151-64. PubMed ID: 1352974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of the apolipoprotein A-IV gene and its significance in lipid metabolism and coronary heart disease in a Japanese population.
    Bai H; Saku K; Liu R; Oribe Y; Yamamoto K; Arakawa K
    Eur J Clin Invest; 1996 Dec; 26(12):1115-24. PubMed ID: 9013087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B, apolipoprotein E, and angiotensin-converting enzyme polymorphisms in 2 Italian populations at different risk for coronary artery disease and comparison of allele frequencies among European populations.
    Corbo RM; Scacchi R; Mureddu L; Mulas G; Castrechini S; Rivasi AP
    Hum Biol; 1999 Dec; 71(6):933-45. PubMed ID: 10592684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age.
    Parlavecchia M; Pancaldi A; Taramelli R; Valsania P; Galli L; Pozza G; Chierchia S; Ruotolo G
    Am J Cardiol; 1994 Aug; 74(4):346-51. PubMed ID: 8059696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
    Azizi F; Rahmani M; Raiszadeh F; Solati M; Navab M
    Coron Artery Dis; 2002 Feb; 13(1):9-16. PubMed ID: 11917194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.
    Bahri R; Esteban E; Moral P; Hassine M; Ben Hamda K; Chaabani H
    Lipids Health Dis; 2008 Nov; 7():46. PubMed ID: 19014618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India.
    Biswas S; Ghoshal PK; Halder B; Ganguly K; DasBiswas A; Mandal N
    Indian Heart J; 2013 Dec; 65(6):658-65. PubMed ID: 24407534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequencies of five genetic polymorphisms in coronarographed patients and effects on lipid levels in a supposedly healthy population.
    Régis-Bailly A; Visvikis S; Steinmetz J; Feldmann L; Briançon S; Danchin N; Zannad F; Siest G
    Clin Genet; 1996 Nov; 50(5):339-47. PubMed ID: 9007321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of polymorphisms in the 5'-flanking region of the apolipoprotein(a) [Apo(a)] gene in Thai subjects with coronary artery diseases.
    Tirawanchai N; Leowattana W; Somkasetrin A; Thongsaen P
    J Med Assoc Thai; 2008 Jan; 91(1):86-92. PubMed ID: 18386550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.